Fig. 1 · Structure
Documents & Downloads
FTT5 LLNs
Lipid-Like Nanoparticles
FTT5 LLNs are functionalized lipid-like nanoparticles designed for efficient in vivo delivery of mRNA and base editing applications. These nanoparticles facilitate targeted delivery, enhancing the stability and bioavailability of nucleic acids in therapeutic contexts. Their utility in genetic research and potential therapeutic interventions makes FTT5 LLNs a critical reagent for advancing mRNA-based technologies and gene editing strategies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2803606-43-9 |
| Applications | Lipid-Like Nanoparticles |
| Formula | C120H222N6O15 |
| Molecular Weight | 1989.08 |
| SMILES | O=C(C1=CC(C(NCCCN(CCCCCCCCC(OC(CCCCC)CC)=O)CCCCCCCCC(OC(CCCCC)CC)=O)=O)=CC(C(NCCCN(CCCCCCCCC(OC(CCCCC)CC)=O)CCCCCCCCC(OC(CCCCC)CC)=O)=O)=C1)NCCCN(CCCCCCCCC(OC(CCCCC)CC)=O)CCCCCCCCC(OC(CCCCC)CC)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.